Regeneron Pharmaceuticals
REGN
REGN
644 hedge funds and large institutions have $29.8B invested in Regeneron Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 216 increasing their positions, 225 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.83% more ownership
Funds ownership: 68.66% → 69.48% (+0.83%)
4% less repeat investments, than reductions
Existing positions increased: 216 | Existing positions reduced: 225
35% less call options, than puts
Call options by funds: $756M | Put options by funds: $1.16B
Holders
644
Holding in Top 10
13
Calls
$756M
Puts
$1.16B
Top Buyers
| 1 | +$703M | |
| 2 | +$294M | |
| 3 | +$130M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$109M |
| 5 |
Morgan Stanley
New York
|
+$77.7M |
Top Sellers
| 1 | -$150M | |
| 2 | -$125M | |
| 3 | -$122M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$105M |
| 5 |
MNG
Manning & Napier Group
Fairport,
New York
|
-$100M |